In the Matter of Carrot Neurotechnology, Inc., File No. 1423132 #00074

Submission Number:
00074
Commenter:
Krish Sathian
State:
Georgia
Initiative Name:
In the Matter of Carrot Neurotechnology, Inc., File No. 1423132
This is an unfortunate occurrence. Dr. Seitz should not be penalized for not conducting randomized, double-blind trials. Such a requirement seems to stem from drug trials and is not easily transported to learning and rehabilitation studies. Before imposing this requirement there needs to be more detailed discussion of the proper approaches by the scientific community.